Related Experiment Video
Updated: Aug 6, 2026

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase
Published on: April 30, 2010
EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation
Beatrice Rondinelli1,2, Ewa Gogola3, Hatice Yücel1
1Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.
Abstract:
The emergence of resistance to poly-ADP-ribose polymerase inhibitors (PARPi) poses a threat to the treatment of BRCA1 and BRCA2 (BRCA1/2)-deficient tumours. Stabilization of stalled DNA replication forks is a recently identified PARPi-resistance mechanism that promotes genomic stability in BRCA1/2-deficient cancers. Dissecting the molecular pathways controlling genomic stability at stalled forks is critical. Here we show that EZH2 localizes at stalled forks where it methylates Lys27 on histone 3 (H3K27me3), mediating recruitment of the MUS81 nuclease. Low EZH2 levels reduce H3K27 methylation, prevent MUS81 recruitment at stalled forks and cause fork stabilization. As a consequence, loss of function of the EZH2/MUS81 axis promotes PARPi resistance in BRCA2-deficient cells. Accordingly, low EZH2 or MUS81 expression levels predict chemoresistance and poor outcome in patients with BRCA2-mutated tumours. Moreover, inhibition of Ezh2 in a murine Brca2-/- breast tumour model is associated with acquired PARPi resistance. Our findings identify EZH2 as a critical regulator of genomic stability at stalled forks that couples histone modifications to nuclease recruitment. Our data identify EZH2 expression as a biomarker of BRCA2-deficient tumour response to chemotherapy.
Insights
EZH2 stabilizes stalled DNA replication forks by recruiting MUS81 nuclease, a key mechanism in BRCA1/2-deficient cancers. Loss of EZH2 or MUS81 promotes resistance to PARP inhibitors (PARPi) and predicts poor patient outcomes.
Area of Science:
- * Molecular biology
- * Cancer research
- * Genomics
Background:
- * Poly-ADP-ribose polymerase inhibitors (PARPi) resistance is a major challenge in treating BRCA1 and BRCA2 (BRCA1/2)-deficient tumors.
- * Stabilization of stalled DNA replication forks is an emerging mechanism of PARPi resistance, promoting genomic stability in these cancers.
- * Understanding the molecular pathways governing genomic stability at stalled forks is crucial.
Purpose of the Study:
- * To investigate the role of EZH2 in regulating genomic stability at stalled DNA replication forks.
- * To determine the molecular mechanisms by which EZH2 influences PARPi resistance in BRCA1/2-deficient cancers.
- * To evaluate EZH2 and MUS81 as potential biomarkers for treatment response.
Main Methods:
- * Investigated EZH2 localization at stalled replication forks.
- * Analyzed the impact of EZH2 on histone H3 lysine 27 trimethylation (H3K27me3) and MUS81 nuclease recruitment.
- * Assessed the consequences of EZH2/MUS81 axis dysfunction on PARPi resistance in BRCA2-deficient cells and a murine model.
- * Correlated EZH2 and MUS81 expression levels with clinical outcomes in patients with BRCA2-mutated tumors.
Main Results:
- * EZH2 was found to localize at stalled replication forks and mediate the recruitment of the MUS81 nuclease via H3K27me3.
- * Reduced EZH2 levels led to decreased H3K27 methylation, impaired MUS81 recruitment, and subsequent fork stabilization.
- * Loss of the EZH2/MUS81 axis conferred PARPi resistance in BRCA2-deficient cells.
- * Low EZH2 or MUS81 expression correlated with chemoresistance and poorer outcomes in patients with BRCA2-mutated tumors.
- * Ezh2 inhibition in a murine Brca2-/- breast cancer model induced acquired PARPi resistance.
Conclusions:
- * EZH2 is a critical regulator of genomic stability at stalled replication forks, linking histone modifications to nuclease recruitment.
- * The EZH2/MUS81 axis is a key determinant of PARPi sensitivity in BRCA2-deficient cancers.
- * EZH2 expression serves as a predictive biomarker for response to chemotherapy in BRCA2-deficient tumors.
More Related Videos
09:14Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 15, 2016
08:53Strand-Specific Analysis of Proteins at Replicating DNA Strands by Enrichment and Sequencing of Protein-Associated Nascent DNA Method
Published on: May 2, 2025
Related Concept Videos
The DNA Replication Fork
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
The DNA Replication Fork
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
DNA Damage Can Stall the Cell Cycle